Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Astellas Pharma Inc banner

Astellas Pharma Inc
OTC:ALPMF

Watchlist Manager
Astellas Pharma Inc Logo
Astellas Pharma Inc
OTC:ALPMF
Watchlist
Price: 16.5 USD 17.86% Market Closed
Market Cap: $29.6B
Write Note Create Alert Ask AI

Wall St Price Targets

ALPMF Price Targets Summary
Astellas Pharma Inc

Wall Street analysts forecast ALPMF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALPMF is 16.8 USD with a low forecast of 11.95 USD and a high forecast of 22.66 USD.

ALPMF Lowest Forecast
Wall Street Target
$11.95
-28% Downside
ALPMF Average Forecast
Wall Street Target
$16.8
2% Upside
ALPMF Highest Forecast
Wall Street Target
$22.66
37% Upside
Lowest Forecast
Price Target
11.95 USD
28% Downside
Average Forecast
Price Target
16.8 USD
2% Upside
Highest Forecast
Price Target
22.66 USD
37% Upside
Astellas Pharma Inc Competitors:
Price Targets
2206
Ezaki Glico Co Ltd
-24% Downside
JEF
Jefferies Financial Group Inc
24% Upside
2206
Ezaki Glico Co Ltd
-24% Downside
JEF
Jefferies Financial Group Inc
24% Upside

Revenue
Forecast

6% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
6% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is -4%.

What are analyst estimates?

Gross Profit
Forecast

7% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
7% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 2 years is -2%.

What are analyst estimates?

Operating Income
Forecast

8% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
8% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 8%.

What are analyst estimates?

Pre-Tax Income
Forecast

9% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
9% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 2 years is 9%.

What are analyst estimates?

Net Income
Forecast

10% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
10% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 2 years is 5%.

What are analyst estimates?

Continue ALPMF Research

Summary
ALPMF intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALPMF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALPMF stock valuation using valuation multiples.
Wall St Estimates
ALPMF price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALPMF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Astellas Pharma Inc listings:
OTC • USD
ALPMY
 F • EUR
YPH
 TSE • JPY
4503
 F • EUR
YPHA
 XMUN • EUR
YPH
 SWB • EUR
YPH
 DUS • EUR
YPH
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ALPMF's stock price target?
Price Target
16.8 USD

According to Wall Street analysts, the average 1-year price target for ALPMF is 16.8 USD with a low forecast of 11.95 USD and a high forecast of 22.66 USD.

What is the Revenue forecast for Astellas Pharma Inc?
Projected CAGR
-4%

Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is -4%.

What is the Gross Profit forecast for Astellas Pharma Inc?
Projected CAGR
-2%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 2 years is -2%.

What is the Pre-Tax Income forecast for Astellas Pharma Inc?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 2 years is 9%.

What is the Net Income forecast for Astellas Pharma Inc?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 2 years is 5%.

Back to Top
ALPHA SPREAD
Follow us
Join 355,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett